Angeliq Online Prescription: How to Actually Get It in the US

This page contains affiliate links to Midi Health and Sesame. We earn a commission if you book through them. Full disclosure. We have no relationship with Push Health and earn nothing from that link.

Yes, a licensed US clinician can prescribe Angeliq online. Not one of the seven telehealth services we checked names it publicly. Here are the three routes that may work, what each costs, and what to verify before you pay.

Is this page for you?

Can you get an Angeliq online prescription in the US?

Yes. A clinician licensed in your state can evaluate you by video or messaging and send an Angeliq prescription to a licensed US pharmacy if they decide it’s appropriate. Angeliq is prescription-only. No legitimate service can promise it before an evaluation.

Here’s what “online prescription” actually means, because the phrase confuses almost everyone:

The clinical evaluation happens online. A licensed pharmacy then dispenses the medicine — locally or by mail.

Three separate steps:

1. You have a consultation with a clinician licensed in your state.
2. The clinician decides. Angeliq is never guaranteed in advance. If someone guarantees it, that’s your signal to leave.
3. The prescription goes to a pharmacy — your local CVS, an independent shop, or a mail-order pharmacy. You pay the pharmacy for the drug separately.

That third step is where most people get stuck, and it’s why this page exists.

What we found when we ran this search

We ran a US-localized search on July 27, 2026. The first page was dominated by international mail-order pharmacies. We read the listings closely. Several make claims that mislead an American reader:

Angeliq prescribing information, DailyMed, checked July 27, 2026.

How to tell a legitimate route from a red flag

The FDA publishes warning signs for unsafe online pharmacies. The practical version:

Do any US menopause telehealth services publicly list Angeliq?

Not one of the seven we checked. On July 27, 2026 we reviewed the public medication pages of seven US telehealth services that treat menopause. Angeliq did not appear on any of them. That doesn’t prove an individual clinician can’t consider it — it means nobody advertises it, so you have to ask before you pay.

A public medication page shows the products a service chooses to name publicly. Not one of them is marketing Angeliq. Here’s what each actually publishes:

Public medication pages as published, reviewed July 27, 2026. None of these pages describes itself as an exhaustive formulary.

The arithmetic that makes this unsurprising

We can’t prove why any provider omits Angeliq. But look at the numbers. Bundled menopause plans that include your medication run roughly $79 to $134 a month. Angeliq’s cash price is $187 to $241 a month. The drug costs more than the entire subscription.

That doesn’t prove causation — a retail coupon price isn’t a provider’s acquisition cost. But when every service promotes low-cost generic regimens, the price gap is worth knowing before you go looking for a plan that includes it.

The reframe that solves your problem

Getting Angeliq online means finding a prescriber, not a store. Specifically: a licensed US clinician who will consider an FDA-approved brand-name request and send the prescription to the pharmacy you choose.

Read that again if you’ve spent an hour searching “buy Angeliq online.” You’ve been searching for the wrong thing.

Three Angeliq-specific checks to raise before booking

Two quick definitions the whole page depends on:

• Estradiol is estrogen. It treats hot flashes and night sweats.
• Drospirenone is a synthetic progestin with antialdosterone activity — it can affect how your body handles potassium. Its job in Angeliq is to protect the uterine lining. It is not micronized progesterone, which is what’s in Bijuva and Prometrium.

Check 1: Do you still have your uterus?

Angeliq’s FDA-approved US indication is for a postmenopausal woman with a uterus (DailyMed, checked July 27, 2026). If you’ve had a hysterectomy, ask a clinician whether an estrogen-alone option is more appropriate. Best online HRT providers for menopause is the more useful page for you.

Check 2: Kidneys and adrenal glands

Renal impairment and adrenal insufficiency are explicit Angeliq contraindications, tied to drospirenone’s effect on potassium. Hepatic impairment is also a contraindication — but that one isn’t unique to Angeliq; other systemic estrogen-plus-progestin products share it.

Check 3: Medicines that raise potassium

Angeliq’s label flags regular use of:

• NSAIDs (ibuprofen, naproxen — including over-the-counter)
• Potassium-sparing diuretics
• Potassium supplements
• ACE inhibitors and ARBs (common blood-pressure drugs)
• Heparin and aldosterone antagonists

Taking one doesn’t automatically rule Angeliq out — it means a conversation rather than an assumption. Bring the list. Don’t stop anything on your own.

The number that gets quoted without its dose

You’ll see this figure on other pages: potassium reached 5.5 mEq/L or higher in 7.3% of women on drospirenone-estradiol versus 2.6% on placebo. Here’s what almost nobody includes: that study used 3 mg of drospirenone. The strongest tablet sold in the US contains 0.5 mg. The study enrolled 230 women who already had high blood pressure or diabetes and were taking an ACE inhibitor or ARB — not a general population.

That study doesn’t directly quantify potassium risk at either US dose. What it does is explain why your prescriber will ask about your kidneys and your medicine list (DailyMed, checked July 27, 2026).

What are Angeliq's contraindications and serious warnings?

Angeliq’s label lists contraindications including undiagnosed abnormal genital bleeding, breast cancer or a history of it, estrogen-dependent cancers, current or previous blood clots, current or previous arterial clotting disease such as stroke or heart attack, known thrombophilic disorders, hypersensitivity, renal impairment, hepatic impairment or disease, and adrenal insufficiency. It also carries a boxed warning. This section summarizes both; the full label is the authority.

The contraindications, in plain language

Angeliq prescribing information, DailyMed, checked July 27, 2026. This is a summary — read the current label with your prescriber.

The boxed warning

When to call rather than wait

Contact a clinician promptly about new, heavy, or persistent vaginal bleeding, or about symptoms of a blood clot — including chest pain, shortness of breath, sudden severe headache, vision changes, or pain and swelling in one leg.

None of this means Angeliq is a uniquely dangerous drug. It means it’s a real medicine with a real label, and the conversation you’re about to have with a prescriber is a real medical conversation. Walk in knowing what’s on the list.

Are overseas Angeliq strengths the same as US Angeliq?

No. US Angeliq comes in two strengths: 0.25 mg drospirenone / 0.5 mg estradiol, and 0.5 mg / 1 mg. The version authorized in the UK contains 2 mg drospirenone / 1 mg estradiol — four times the drospirenone of the strongest US tablet. Same brand name, same two ingredients, different strength and a different national approval.

One note before the table: the UK names the product estradiol-first. What’s sold there as “Angeliq 1 mg/2 mg” means 1 mg estradiol plus 2 mg drospirenone. To avoid confusion, every number below is in drospirenone / estradiol order.

US strengths and indications: Angeliq prescribing information, DailyMed, checked July 27, 2026. UK strength and indications: UK Summary of Product Characteristics for Angeliq.

Do the math on what that means

Say your prescription reads 0.25 mg / 0.5 mg — the strength the label directs you to start on for hot flashes. The overseas product delivers eight times that drospirenone in each tablet. That’s not a small rounding difference. It’s a different drug in everything except the name on the box.

Is it legal to order Angeliq from overseas?

Generally, no. Personal importation of an unapproved prescription drug into the US is generally unlawful, though the FDA has described narrow circumstances in which it may exercise enforcement discretion for personal-use quantities. For Angeliq specifically, legality isn’t even the biggest issue — the product sold abroad is a different strength than your US prescription authorizes.

One international seller listed 84 tablets at $116 on July 27, 2026 — about $38.67 per 28 days versus $187 to $241 in the US. The savings are real. But the strongest product authorized abroad contains four times the drospirenone of the strongest tablet approved here. That’s not a price question. It’s a “this is a different strength than my prescription says” question.

Which US telehealth routes may evaluate an Angeliq request?

Three models publicly state that their clinicians can send prescriptions to a pharmacy you choose: an insurance-billing menopause clinic, a cash marketplace where you pick your own clinician, and a request-based service for continuing an existing regimen. None names Angeliq publicly, and none confirmed exact-drug support when we checked. Ask before you pay.

Every claim in the table below carries one of three labels: provider-stated (published on the company’s own site), independently checked (confirmed against a public primary source), or not verified (we couldn’t confirm it, and we’re saying so instead of guessing).

Provider pricing and policies as published, checked July 2026. Confirm current prices at booking — they move.

Route 1: Midi Health — if you have commercial insurance

The punchline first: if you want menopause-focused care and want your visit run through commercial insurance, Midi is the strongest fit of the three models here.

Midi is a virtual menopause clinic. Its clinicians treat menopause all day, it operates in all 50 states, and it sends prescriptions to the pharmacy you name — which is exactly what an Angeliq request needs.

The reason the insurance question matters more here than on most pages: the visit is a one-time cost. The drug is a monthly one. At $187 to $241 a month, whether your plan covers Angeliq will dwarf what you paid for the consult by March. A clinician who can bill your plan for the visit is also a clinician positioned to help with a prior-authorization request if your plan needs one.

Self-pay pricing: $250 for a first visit, $150 for follow-up visits (provider-stated, July 2026). If you have insurance, that’s covered at your plan’s applicable rate.

Important: Midi cannot treat Medicaid or Medi-Cal patients. Medicare beneficiaries may use Midi as self-pay only — no claims are submitted to Medicare.

Route 2: Sesame — if you're paying cash and want to pick your clinician

The punchline first: Sesame is a cash marketplace. You pick your own clinician rather than being matched. That matters here because you can look for someone who treats menopause specifically, rather than hoping the person you get does.

For everyone else:

• Visits start at $34 — but that’s the general platform starting price, not a menopause or gynecology visit. Check the real number for your ZIP. It’s shown before you book.
• Sesame provides a prescription savings card, but your medication is not included in any visit price. You fill it and pay at your pharmacy.
• If you take a Sesame membership, the current terms require cancelling at least 48 hours before the renewal date. Set a reminder.

Route 3: Push Health — if you already take Angeliq and need it continued

The punchline first: if you have an established regimen and a straightforward continuation request, this may be a lower-friction model — and we make nothing from telling you about it.

Push Health is request-based. You submit a request, it matches you with an available provider licensed in your state, and that provider sets their own fee and makes their own prescribing decisions. No membership, no subscription.

We’re including it because it fits one specific reader: you’ve taken Angeliq before, you know your strength, and you need someone to review and continue it.

Be clear-eyed about the trade-offs:

• You don’t pick your provider — you’re matched. Support can rematch you.
• There’s no published price for a hormone consult. You’ll see the fee before you authorize it.
• You may see $64.99–$80 quoted elsewhere. That figure comes from a Push Health support article dated March 2022. Don’t plan around it.
• Refunds are limited. Full refund before the provider writes the prescription. Not after.
• The recurring complaint across review sources is response time. It’s a marketplace, so the experience varies with whoever picks up your request.
• Push Health names FDA-approved brands like Climara, Estrace, and Vivelle-Dot — but not Angeliq. Same rule as everyone else: ask before you pay.

One consumer-report datum, dated and in context: Push Health held a C rating with the Better Business Bureau and was not BBB-accredited when we checked in July 2026. A BBB rating reflects complaint handling and business practices — it doesn’t verify prescribing quality or whether any clinician will consider Angeliq.

If you’re new to HRT, unsure of your dose, or want someone who’ll follow up and adjust, this is the wrong route. Go back to Midi or Sesame.

Route 4: The prescriber you already have

Don’t skip this one. If you have a valid prescription with refills left, you may not need another consultation at all. Before you pay anyone:

1. Call your pharmacy and confirm they can order your exact strength.
2. If they can’t, ask which nearby pharmacy can.
3. If it’s a refill problem, message your existing prescriber’s office first. A refill request is usually free.

We’d rather you spend nothing than spend $250 you didn’t need to.

If you're on Medicare or Medicaid

Sesame excludes Medicare, Medicaid, and TRICARE beneficiaries under its current terms. Midi may accept Medicare beneficiaries as self-pay but does not bill Medicare, and cannot treat Medicaid or Medi-Cal patients.

Your practical path is an in-network local prescriber plus your plan’s formulary process. There is no honest affiliate link in this section — there isn’t one to give you.

Providers we're deliberately not recommending here

Hers prescribes FDA-approved estradiol plus micronized progesterone. No drospirenone. It is not a route to Angeliq and we won’t imply it is. It’s a legitimate option if you decide a different combination works for you.

Winona and Inner Balance (Oestra) center on compounded preparations. Compounded medications are custom-mixed by a pharmacy and are not FDA-approved; the FDA does not evaluate them for safety, effectiveness, or quality before use. Angeliq is an FDA-approved brand-name product — a different regulatory category entirely.

How much does Angeliq cost in the US?

Angeliq’s cash price runs about $187 to $241 for 28 tablets of the 0.5 mg / 1 mg strength, based on SingleCare pricing checked in July 2026. That’s the medicine only — your consultation, any lab work, and follow-up visits are separate. Prices vary by pharmacy and ZIP code.

SingleCare pricing for Angeliq 0.5 mg / 1 mg, 28 tablets. Price data stamped July 9, 2026; page checked July 27, 2026. Confirm with your pharmacy — these move by ZIP.

Two things to notice. First, the same drug is $28 cheaper at one chain than another on the discount card. Don’t fill at whichever pharmacy is closest without checking. Second, watch for a figure of $184.08 on price-comparison pages — that includes a one-time $3 new-member credit. The price you’ll pay every month after that is $187.08.

On coupons and insurance: they’re usually two different ways to pay, not two discounts you stack. Ask the pharmacist to run both and tell you which is lower.

Does insurance cover Angeliq?

It depends entirely on your plan, and Angeliq is a harder-than-average drug to get covered. It’s a brand-name product with no widely stocked generic, so plans that cover it usually put it on a high tier — and many require you to try a generic combination first.

Six things determine your answer:

If your plan does require step therapy, your prescriber can document the reason for choosing drospirenone specifically — that documentation is what prior-authorization paperwork needs. A clinician who handles this regularly will know the process. One who doesn’t may leave you restarting from scratch at the pharmacy counter.

Is there a generic Angeliq in 2026?

One generic was FDA-approved on October 28, 2025 for the 0.5 mg / 1 mg strength only. We could not confirm it has launched commercially or that pharmacies can reliably order it. No generic is currently approved for the 0.25 mg / 0.5 mg starting strength.

If you ask your pharmacist about a generic and they say yes, ask them to price it against the brand with your discount card. But don’t plan around a launch we can’t verify — the absence of pricing at a secondary site isn’t proof no supply exists, but it’s not confirmation it does either.

What should you ask before an Angeliq consultation?

Asking about a specific brand is normal and prescribers handle it every day. What makes the conversation productive is bringing relevant history rather than a demand — specifically, why a drospirenone-containing product instead of the generic combination most prescribers and plans reach for first.

A question a clinician may ask

“Why not estradiol with norethindrone?” It’s a fair question. That combination is FDA-approved, treats the same symptom categories, and costs dramatically less. History that’s worth sharing: you’ve tried a different progestin and didn’t tolerate it; a clinician previously chose drospirenone for a documented reason; you’ve taken Angeliq before and it worked. None of that obligates anyone to prescribe Angeliq. It gives your prescriber something to work with.

Ask this before you pay any provider

Send it to support before checkout. If they can’t answer it clearly, you’ve just saved yourself a consult fee.

Questions for the visit itself

• Is Angeliq a reasonable option for my symptoms and history?
• Should I start at 0.25 / 0.5 or 0.5 / 1?
• Do any of my medications create a potassium concern?
• Is there a reason a patch or gel would suit me better?
• What happens if my pharmacy can’t get it?
• Will my plan need a prior authorization, and can you help with it?
• When do I check back in with you?

Bring these to the appointment

• Your current package or bottle, if you have one
• Every medication and supplement you take, including over-the-counter
• What you’ve tried before and what happened
• Your pharmacy’s name and phone number
• Your insurance card

What should you do if your pharmacy cannot get Angeliq?

Ask which problem it actually is. A pharmacy’s inability to fill Angeliq can reflect local inventory, wholesaler availability, the exact strength or NDC on your prescription, insurance-network rules, or a broader supply issue. Those have completely different fixes.

We searched the FDA Drug Shortages database on July 27, 2026 and did not find Angeliq listed. That’s a snapshot, not a guarantee that every wholesaler has supply.

The five-step workflow:

1. Confirm your exact strength and quantity before the prescription goes anywhere.
2. Ask your pharmacy to check on-hand stock and wholesaler availability — two different questions.
3. Ask whether it can be special-ordered, and how long that takes.
4. If not, call around — another chain, an independent pharmacy, and your plan’s mail-order option.
5. Only then decide whether to transfer the prescription or go back to your prescriber.

One headline that isn’t about you: there’s real supply strain on estradiol patches in 2026. That’s a different product from Angeliq, which is an oral tablet. If you’ve seen patch headlines and assumed they explain your problem, they don’t.

Has Angeliq's warning label been updated?

Not as of our check. In November 2025 the FDA requested that manufacturers remove certain cardiovascular, breast cancer, and dementia language from boxed warnings on menopause hormone therapy, and approved revised labels for six products in February 2026. Angeliq’s public US label still shows “Revised: 12/2023” and still carries the prior boxed-warning language. We checked this on July 27, 2026.

Here’s the detail that causes confusion: the DailyMed page shows an update date of March 2, 2026. But the label content is stamped December 2023, and the Recent Major Changes section lists only a boxed-warning change from October 2023 and a warnings change from December 2023. The March 2026 posting wasn’t a change to what the label says.

Two generic estradiol gel products from different manufacturers did record the removals in February 2026 — so right now, two FDA-approved estrogen products carry meaningfully different boxed warnings. We can’t tell you why Angeliq’s hasn’t changed yet, or when it will. Removing a warning does not remove the underlying risk. Talk about your own risk with your prescriber, not with a headline.

Does Bayer offer an Angeliq savings card or patient assistance?

Angeliq is not on the Bayer Savings Card. That program lists four products — Natazia, Climara Pro, Lampit, and Betaseron — and Angeliq is not among them, despite what several pages currently say. We checked Bayer’s own savings-card program page on July 27, 2026.

But Angeliq does appear on the Bayer US Patient Assistance Foundation’s eligibility tool and enrollment form — a separate program that can provide medicine at no charge to people who qualify.

What we found on Bayer’s Patient Assistance program — and it’s strange

Bayer publishes two different product lists on two pages of the same website, both stamped “Last Updated: Friday, January 09, 2026.”

The product-list page is the one linked under “About,” and it’s the page most people land on. If you read only that page, you’d conclude Angeliq isn’t covered and stop. The Find Help Tool is the page that actually produces your application. Angeliq is on it.

How to apply

Use Bayer’s Find Help Tool to check eligibility. Don’t conclude you’re ineligible from the shorter product-list page.

The basic requirements: you live in the US or Puerto Rico, you meet the income limits (Bayer publishes a general standard of 300% of the federal poverty level for most medicines), and you either have no insurance or your Bayer medicine isn’t covered. If the tool says you may qualify, you download the form, complete the patient section, have your prescriber complete the clinical section, and fax or mail it. The Foundation’s number is 1-866-228-7723. If approved, the program can provide the medicine at no charge. Approval isn’t guaranteed.

And please don’t pay anyone to file this. There are services that charge a monthly fee to submit patient-assistance paperwork. Applying directly is free. The form is free. The phone call is free.

What did Angeliq's trials show in the first 12 weeks?

In the randomized trial of the 0.25 mg / 0.5 mg strength, the treatment group had a significantly greater average reduction in hot flushes than placebo at both week 4 and week 12. Group results don’t predict when or how much any individual will improve.

The numbers, with the part usually left out

Women entered the trial with about 10.7 hot flushes a day. At week 12:

• Angeliq group: down 7.71 a day
• Placebo group: down 4.54 a day
• Difference: 3.17 a day (95% CI −3.97 to −2.37, p<0.0001)

The drug clearly beat placebo, and that result is solid. But a large share of the total improvement people feel shows up on placebo too. That’s normal in hot-flash research, and knowing it will keep your expectations honest. (Angeliq prescribing information, DailyMed, checked July 27, 2026.)

Bleeding

At one year, about 15% of women on the lower strength and 22% on the higher strength still reported any bleeding or spotting, and that proportion fell over time. Postmenopausal bleeding was one of several commonly reported reasons for stopping — along with abdominal pain, headache, breast tenderness, and weight increase. Set the expectation now so it doesn’t frighten you in month two. Contact your prescriber about bleeding that’s new, heavy, or persistent.

Which strength to start on

The label directs starting vasomotor-symptom treatment at 0.25 mg / 0.5 mg. Only the 0.5 / 1 strength carries the vulvar and vaginal atrophy indication — and even there, the label’s limitation of use says that when vaginal symptoms are the only reason for treatment, topical vaginal products should be considered first.

Why the second hormone is in there

Over 12 months, endometrial hyperplasia was found in 0 of 407 biopsies on the lower strength, 0 of 191 on the higher strength, and 8 of 197 (4%) on estradiol alone. The progestin component is included to reduce the risk of estrogen-induced endometrial hyperplasia in a woman with a uterus. That’s what it’s for.

If you take thyroid medication

Estrogen can increase thyroid-binding globulin, and the label says women on thyroid replacement should have thyroid function monitored — they may need a dose adjustment (DailyMed, checked July 27, 2026). Mention it at your visit so nobody’s surprised by a lab result in three months.

What are the alternatives if Angeliq isn't a fit?

Several other FDA-approved options treat similar symptoms, but they use different ingredients, routes, indications, and contraindications. Which one fits depends on why Angeliq doesn’t.

Not sure which product fits you? Combination HRT online covers the full category — every FDA-approved estrogen-plus-progestin option with routes and costs side by side.

Common questions about Angeliq online

Can I buy Angeliq online without a prescription?

No. Angeliq is prescription-only in the US. A site selling it without a prescription is a red flag under the FDA’s own guidance, however professional it looks.

Can a telehealth doctor prescribe Angeliq?

Yes, if they’re licensed in your state and decide it’s appropriate for you. No legitimate service will promise the outcome before your visit.

Does any telehealth service include Angeliq in its monthly plan price?

None of the seven US services we checked names Angeliq on its public medication page. Bundled menopause plans run $79–$134 a month including medication, while Angeliq alone costs $187–$241. The drug costs more than the entire subscription price at most services.

Is there a generic Angeliq?

The FDA approved one on October 28, 2025 for the 0.5 mg / 1 mg strength. We could not confirm it has launched or that pharmacies can reliably order it. No generic is approved for the 0.25 mg / 0.5 mg starting strength.

What is drospirenone, and why does it matter?

Drospirenone is a synthetic progestin with antialdosterone activity. In Angeliq, it protects the uterine lining from the estrogen. It is not the same as micronized progesterone. Its antialdosterone activity is why Angeliq has drospirenone-specific contraindications (renal impairment, adrenal insufficiency) and why it requires review if you take medications that raise potassium.

Does Angeliq protect bones?

Not in its US label. Angeliq is authorized for osteoporosis prevention in some other countries — which is why overseas sellers sometimes make that claim. The US approval covers moderate-to-severe hot flashes and night sweats, and vaginal atrophy (higher strength only). If bone protection is a priority, Activella has that indication in its US label.

How did The HRT Index verify this page?

Independently checked against public sources on July 27, 2026:

• Angeliq’s US prescribing information on DailyMed — strengths, indications, contraindications, boxed warning status, and trial data
• The UK Summary of Product Characteristics for Angeliq — strength and indications
• Both Bayer Patient Assistance Foundation pages. They don’t match. Angeliq appears on the eligibility tool
• Bayer’s savings-card covered-product list — Angeliq is not on it
• SingleCare pricing by chain for the 0.5 mg / 1 mg strength
• Generic approval status in the FDA’s first-generic approvals record
• The FDA Drug Shortages database — Angeliq not found on that date
• The public medication pages of seven US telehealth providers
• Published pricing, state, and terms pages for Midi Health, Sesame, and Push Health

What we could not verify:

• Whether any provider will consider Angeliq — none names it publicly and we did not receive direct confirmation from any of them
• Whether the Novast generic has launched — approval is confirmed, commercial availability is not
• Why Bayer’s two product lists disagree — we report what both pages said on the day we checked
• Your plan’s specific coverage — that’s plan-specific

Who wrote this: The HRT Index Editorial Team. Desk research against primary sources. Not reviewed by a clinician. See our medical review policy.

Found something out of date? Tell us. We date every claim so you can hold us to it.